Ausgabe 3/2002
Inhalt (11 Artikel)
HMG-I/Y in human breast cancer cell lines
Christine E. Dolde, Mita Mukherjee, Chung Cho, Linda M.S. Resar
p53 expression is a factor for prognostic assessment in breast sarcoma
Maria do Socorro Maciel, Leda C. Viegas, Suely Nonogaki, Inês N. Nishimoto, Fauzer S. Abrão, Mário Mourão Neto, M. Mitzi Brentani
Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer
Nam Deuk Kim, Rajendra Mehta, Weiping Yu, Ishak Neeman, Talia Livney, Akiva Amichay, Donald Poirier, Paul Nicholls, Andrew Kirby, Wenguo Jiang, Robert Mansel, Cheppail Ramachandran, Thangaiyan Rabi, Boris Kaplan, Ephraim Lansky
Large expansion of morphologically heterogeneous mammary epithelial cells, including the luminal phenotype, from human breast tumours
L. Krásná, D. Dudorkinová, J. Vedralová, P. Veselý, E. Pokorná, I. Kudláčková, A. Chaloupková, L. Petruželka, J. Daneš, E. Matoušková
Multidrug-resistant MCF-7 breast cancer cells contain deficient intracellular calcium pools
Jack S.K. Chen, Neeraj Agarwal, Kapil Mehta
Expression of estrogen receptor beta isoforms in human breast cancer tissues and cell lines
Dan Tong, Eva Schuster, Michael Seifert, Klaus Czerwenka, Sepp Leodolter, Robert Zeillinger
Distinct mechanisms of bisphosphonate action between osteoblasts and breast cancer cells: identity of a potent new bisphosphonate analogue
Gregory G. Reinholz, Barbara Getz, Emily S. Sanders, Marat Ya. Karpeisky, Nelly Sh. Padyukova, Sergey N. Mikhailov, James N. Ingle, Thomas C. Spelsberg
Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells
Robert-Alain Toillon, Valérie Chopin, Nathalie Jouy, William Fauquette, Bénoni Boilly, Xuefen Le Bourhis